Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170401 · ClinicalTrials.gov registry record · Phase 3
Supplemental Enteral Protein in Critical Illness
A Phase 3 study of Critical Illness and Trauma, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03170401: Completed Phase 3 study of Critical Illness and Trauma, sponsored by University of Washington.
NCT03170401 is a Phase 3 study of Critical Illness and Trauma that has completed, run by University of Washington. The registered enrollment target is 500 participants, below the 3,133-participant average among 91 other Critical Illness trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03170401, a Phase 3 study of Critical Illness and Trauma, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is too determine the effect of enteral protein supplementation on biochemical measures of inflammation and protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, duration of mechanical ventilation and other measures of recovery from critical illness. Hypothesis: That early supplemental protein will increase serum concentrations of transthyretin at three weeks after the onset of illness or injury. Secondarily, the investigators will test whether supplementation, reduces infectious complications and increases ventilator-free days.
Primary Outcome
Transthyretin is a circulating biomarker of nutritional status and protein synthesis.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Protein supplementation
- OTHER Standard enteral nutrition
Study Locations (1)
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-12 |
| Phase | Phase 3 |
What the finished NCT03170401 record still lists
NCT03170401 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 3,133-participant average among 91 other Critical Illness trials with a reported enrollment target (84% lower).
The record links to 3 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Protein supplementation is the first listed.
NCT03170401 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03170401 about?
NCT03170401 is a clinical study titled "Supplemental Enteral Protein in Critical Illness". The aim of this study is too determine the effect of enteral protein supplementation on biochemical measures of inflammation and protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, durati...
What is the current status of trial NCT03170401?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2016-11. Estimated completion is 2022-12.
What conditions does trial NCT03170401 study?
This clinical trial studies the following conditions: Critical Illness, Trauma, Nutrition Disorder.
What interventions are being tested in trial NCT03170401?
The interventions under investigation include: Protein supplementation (DIETARY_SUPPLEMENT), Standard enteral nutrition (OTHER).
Who is sponsoring clinical trial NCT03170401?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03170401 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03170401's enrollment target sits among peer trials
500 27th of 91 higher than 63 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
RECRUITING · Phase 3
-
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
ACTIVE NOT RECRUITING · Phase 3
-
Strategy to Avoid Excessive Oxygen in Major Burn Patients
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Mechanisms of GLN Dipeptide in the SICU
COMPLETED · Phase 3
-
Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
COMPLETED · Phase 3
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia